Who is sponsoring NCT05002751?

NCT05002751 is sponsored by University of California, San Diego.

What drugs are being tested in NCT05002751?

Interventions in NCT05002751: UCSD Vaginal Dilator Questionnaire, EORTC Sexual Health Questionnaire.

What condition does NCT05002751 study?

NCT05002751 studies Vaginal Stricture, Vaginal Stenosis.

Is NCT05002751 still recruiting?

NCT05002751 is currently recruiting now. Last updated 9 July 2025.

Last reviewed 2025-07-09 · How we verify

NCT05002751: QRIVS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Quantifying Radiation Induced Vaginal Stenosis

Recruiting now Last updated 9 July 2025

What this trial tests

trial testing UCSD Vaginal Dilator Questionnaire in Vaginal Stricture in 12 participants. Currently enrolling.

Timeline

6 October 2022

Primary endpoint
5 April 2026

28 February 2027

Quick facts

Lead sponsor	University of California, San Diego
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	12
Start date	6 October 2022
Primary completion	5 April 2026
Estimated completion	28 February 2027
Sites	1 location across United States

Drugs / interventions tested

UCSD Vaginal Dilator Questionnaire
EORTC Sexual Health Questionnaire

Conditions studied

Vaginal Stricture — all drugs for Vaginal Stricture →
Vaginal Stenosis — all drugs for Vaginal Stenosis →

Sponsor

University of California, San Diego

Who can join

Adults 18 to 99, female only, with Vaginal Stricture or Vaginal Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Radiation (RT) affects the vagina by narrowing, tightening and scarring, termed vaginal stenosis (VS). VS occurs in up to 88% of patients treated with radiation for cervical cancer. VS is not well characterized in measurements. There is a lack of understanding of how short and tight the vagina becomes after RT. This study will use specific measurements of the vagina during the routine physician physical exam after RT in the follow up periods: after RT, 3 months, 6 months, and 12 months using a plastic commercial dilator set and length and width measurements. In addition, the study use a validated sexual health survey and a specific survey on vaginal dilation preferences to help stop VS after RT.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of California, San Diego trials

Trials by the same sponsor.

NCT07342543 — Guided Physical Activity Counseling for Hypertension in Primary Care · NA · not yet recruiting
NCT06505317 — Artificial Intelligence for Early Detection of Peripheral Artery Disease · NA · not yet recruiting
NCT07211802 — CKM For Safe Use of SGLT2i in Type 1 Diabetes · Phase 3 · not yet recruiting
NCT07524751 — Culturally Adapted Pain Management for Indigenous Peoples · NA · not yet recruiting
NCT07518784 — Accurate Point of Care Liver Disease Diagnostics (Phase 2) · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05002751 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, San Diego
Last refreshed: 9 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05002751.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing